Urelumab (Anti-TNFRSF9 / 4-1BB / CD137)

Urelumab (Anti-TNFRSF9 / 4-1BB / CD137) is a fully human agonistic monoclonal antibody targeting the CD137 receptor with potential immunostimulatory and antineoplastic activities. MW : 146.5 KD.
Supplier Selleck Chemicals
Product # A2321
Sku # A2321-1mg*5
Pricing 1mg*5, $1970.00
Feedback